ArticleBiomedicines2022

Sorafenib versus Lenvatinib Causes Stronger Oxidative Damage to Membrane Lipids in Noncancerous Tissues of the Thyroid, Liver, and Kidney: Effective Protection by Melatonin and Indole-3-Propionic Acid.

Jan Stępniak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.